Millennium Management
MRVI icon

Millennium Management’s Maravai LifeSciences MRVI Stock Holding History

Millennium Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.67M Sell
1,649,490
-147,562
-8% -$500K ﹤0.01% 3021
2025
Q4 		$5.84M Buy
1,797,052
+1,357,349
+309% +$4.57M ﹤0.01% 2840
2025
Q3 		$1.26M Buy
439,703
+191,616
+77% +$489K ﹤0.01% 4440
2025
Q2 		$598K Sell
248,087
-1,128,634
-82% -$2.37M ﹤0.01% 4780
2025
Q1 		$3.04M Sell
1,376,721
-530,540
-28% -$2.1M ﹤0.01% 3377
2024
Q4 		$10.4M Sell
1,907,261
-2,418,051
-56% -$15.6M 0.01% 2142
2024
Q3 		$35.9M Sell
4,325,312
-1,643,280
-28% -$14.2M 0.02% 1058
2024
Q2 		$42.7M Buy
5,968,592
+713,639
+14% +$6.16M 0.02% 907
2024
Q1 		$45.6M Sell
5,254,953
-531,896
-9% -$3.6M 0.02% 883
2023
Q4 		$37.9M Buy
5,786,849
+1,524,650
+36% +$9.85M 0.02% 998
2023
Q3 		$42.6M Buy
4,262,199
+4,040,786
+1,825% +$44.4M 0.02% 814
2023
Q2 		$2.75M Buy
221,413
+211,020
+2,030% +$2.85M ﹤0.01% 3201
2023
Q1 		$146K Sell
10,393
-2,585,155
-100% -$37.1M ﹤0.01% 5290
2022
Q4 		$37.1M Buy
2,595,548
+799,274
+44% +$12.6M 0.02% 959
2022
Q3 		$45.9M Buy
1,796,274
+1,687,021
+1,544% +$42.3M 0.03% 727
2022
Q2 		$3.1M Sell
109,253
-555,426
-84% -$17.6M ﹤0.01% 3263
2022
Q1 		$23.4M Buy
664,679
+143,060
+27% +$4.8M 0.01% 1227
2021
Q4 		$21.9M Buy
521,619
+142,869
+38% +$5.79M 0.01% 1353
2021
Q3 		$18.6M Buy
378,750
+100
+0% +$4.88K 0.01% 1400
2021
Q2 		$15.8M Buy
378,650
+13,045
+4% +$506K 0.01% 1430
2021
Q1 		$13M Sell
365,605
-340,093
-48% -$11.3M 0.01% 1509
2020
Q4 		$19.8M Buy
+705,698
New +$19.7M 0.01% 1080

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's MRVI Position: Q1 2026 in Review

Millennium Management reduced its Maravai LifeSciences (MRVI) stake by 8.2% in Q1 2026, selling an estimated $500K and leaving 1,649,490 shares worth $4.67M. The position accounts for ﹤0.01% of the portfolio, ranked #3021.

Millennium Management first reported a position in MRVI in Q4 2020 and has held it in 22 quarters since. The position peaked at $45.9M in Q3 2022. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Millennium Management held 1,649,490 shares of Maravai LifeSciences worth $4.67M as of Q1 2026.
  • Millennium Management sold 147,562 Maravai LifeSciences shares in Q1 2026, an estimated $500K.
  • Maravai LifeSciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3021 holding.
  • Millennium Management first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 22 quarters since.
  • Millennium Management's Maravai LifeSciences position peaked at $45.9M in Q3 2022.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.